Insider · CIK 0001801372

Lee Jennifer Kayden

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001801372

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−75.8K sh	$117.38	−$8.9M	0
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+21.6K sh	$6.80	+$147K	75,834
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−35K sh	—	—	36,283
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+35K sh	$24.29	+$850K	54,233
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−21.6K sh	—	—	0
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	EVP, Head of North America	AAward	+32.5K sh	—	—	32,500
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP, Head of North America	AAward	+21.7K sh	—	—	21,650
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−3,437 sh	—	—	0
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	EVP, Head of North America	FTax Payment	−9,237 sh	$108.99	−$1.01M	19,233
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−9,163 sh	—	—	27,487
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+22.6K sh	—	—	28,470
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−5,500 sh	—	—	11,000
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−4,512 sh	—	—	4,512
2025-02-19	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−2,035 sh	$57.22	−$116K	5,858
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+5,500 sh	—	—	7,893
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−5,500 sh	—	—	16,500
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	EVP, Head of North America	AAward	+55K sh	—	—	55,000
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP, Head of North America	AAward	+36.7K sh	—	—	36,650
2025-02-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,205 sh	$58.00	−$69.9K	2,393
2025-02-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−10 sh	$56.41	−$564.1	4,803
2025-02-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−600 sh	$56.39	−$33.8K	4,813
2025-02-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,205 sh	$56.39	−$67.9K	3,598
2025-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−2,031 sh	—	—	0
2025-02-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−4 sh	$57.50	−$230	5,413
2025-02-11	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+2,031 sh	—	—	6,440
2025-02-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,023 sh	$57.51	−$58.8K	5,417
2025-02-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−2,295 sh	$59.34	−$136K	4,409
2025-02-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,894 sh	$58.39	−$111K	6,704
2025-02-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−4,189 sh	—	—	21,601
2025-02-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−3,437 sh	—	—	3,437
2025-02-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+3,437 sh	—	—	4,409
2025-02-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+4,189 sh	$6.80	+$28.5K	8,598
2025-02-05	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−200 sh	$61.95	−$12.4K	972
2025-02-05	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,133 sh	$61.01	−$69.1K	1,172
2025-02-05	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,733 sh	$60.08	−$104K	2,305
2025-02-04	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−1,447 sh	$59.43	−$86K	4,038
2025-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+4,513 sh	—	—	5,485
2025-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−4,513 sh	—	—	9,024
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−11.1K sh	$67.56	−$748K	1,172
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+11.6K sh	$30.66	+$357K	67,833
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+28.7K sh	$24.29	+$698K	56,191
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−28.7K sh	—	—	71,283
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−17.5K sh	$66.95	−$1.17M	12,242
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−11.6K sh	—	—	37,108
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	+20.6K sh	$6.80	+$140K	27,474
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−38.1K sh	$65.68	−$2.5M	29,782
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−200 sh	$68.43	−$13.7K	972
2024-11-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Head of North America	MExercise/Conversion	−20.6K sh	—	—	25,790
2024-03-20	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−9,169 sh	$38.22	−$350K	15,918
2024-03-20	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	EVP, Head of North America	SSale	−9,066 sh	$39.33	−$357K	6,852

Recent filings

Accepted (ET)
Aug 144
Lee Jennifer Kayden0001649904-26-000009
SEC(opens sec.gov)
Feb 134
Lee Jennifer Kayden0001104659-26-015399
SEC(opens sec.gov)
Feb 34
Lee Jennifer Kayden0001104659-26-009767
SEC(opens sec.gov)
Feb 194
Lee Jennifer Kayden0001104659-25-015320
SEC(opens sec.gov)
Feb 144
Lee Jennifer Kayden0001104659-25-014257
SEC(opens sec.gov)

Companies

Address

C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116